¿Una alternativa para potenciar la eficacia de las vacunas contra el SARS-CoV-2?

1. Haq K, McElhaney JE. Immunosenescence: Influenza vaccination and the elderly. Curr. Opin. Immunol. 2014, 29, 38–42.

 2. Lei WT, Shih PC, Liu SJ et al. Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: A systematic review and meta-analysis of randomized controlled trials. Nutrients 2017, 9, 1175.

3. Grant WB, Lahore H, McDonnell SL et al.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4).

4. Mariani J, Tajer C, Antonietti L et al. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: study protocol of a multicentre, randomized, controlled clinical trial (CARED TRIAL). Trials 2021;Feb 1;22(1):111. doi: 10.1186/s13063-021-05073-3

5. Mariani J, Giménez VMM, Bergam I et al. Association Between Vitamin D Deficiency and COVID-19 Incidence, Complications, and Mortality in 46 Countries: An Ecological Study. Health Secur. 2020 Dec 14. doi: 10.1089/hs.2020.0137

6. Petrelli F, Luciani A, Perego G et al.  Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol. 2021 Mar 26;211:105883. doi: 10.1016/j.jsbmb.2021.105883.